Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine versus morphine added to Transtec for breakthrough osteoarthritis pain
2005-003230-18Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Sep 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of buprenorphine and morphine in osteoarthritis (OA) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoints: Number of responders and Global satisfaction with analgesic treatment. Started Sep 2005; status: completed.
02
Drugs
buprenorphinemorphine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-003230-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003230-18.